Celexa and Birth Defects
We are dedicated to helping those who have been injured or affected by a catastrophic injury. You may contact us 24/7 at (832) 690-7000 for a free, confidential consultation or to schedule an appointment with us.
Legally Reviewed By
Celexa (Citalopram) is in a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). Celexa is used to treat depression, anxiety, panic disorder and body dysmorphic disorder. The Food and Drug Administration (FDA) approved Celexa for treatment of depression in 1998.
Celexais currently classified as a Pregnancy Category C drug. There has been animal study evidence indicating that Celexa may have an adverse effect on the fetus when ingested during pregnancy.
No items found.
No items found.
Studies Have Found a Link Between Celexa and Birth Defects
Celexa has been linked to a wide array of birth defects, including heart and neural tube defects:
- In 2009, the British Medical Journal discovered that there was an increased risk of septal heart defects
- In 2010, the Clinical Epidemiology Journal found that there was an association between Celexa and overall malformations
- In 2011, Obstetrics & Gynecology Journal linked neural tube defects to the ingestion of Celexa during pregnancy.
Additionally, the FDA issued a warning in 2006, for all SSRIs including Celexa, regarding the association between persistent pulmonary hypertension in newborns (“PPHN”) and SSRIs.
Forest Laboratories has faced enormous controversy since the introduction of Celexa onto the U.S. market. In 2004, Forest Laboratories was accused of illegally marketing Celexa for use n children and teenagers. Forest Laboratories pled guilty to obstruction of justice and illegally promoting its drugs Lexapro and Celexa and paid $313 million including $164 million in criminal penalties.
In August 2011, the FDA revised the labeling for Celexa to warn patients that taking more than 40 mg per day could lead to an increased risk of abnormal heart rhythms. The label change comes on the heels of a published study that demonstrated higher doses of Celexa were associated with an increased risk of heart problems.
In March 2012, the FDA changed the warning label for Celexa, to alert patients that the drug is not recommended in patients with long QT syndrome.
Fill Out Our Form For Your Free Consultation
Celexa Lawsuit
Pierce | Skrabanek has extensive experience handling birth defect lawsuits. It is important to contact a lawyer with the knowledge necessary to handle your birth defect lawsuit. We are currently accepting Celexa birth defect cases. Please contact us for a free case evaluation. We handle all cases on a contingency basis meaning we don’t get paid unless we win.
What Our Clients Are Saying About Us
Frequently Asked Questions
No items found.
We’re Here for You:
Real Results for Real Challenges
We know how tough things can get after an injury. That’s why we make your struggles our fight. With over three decades of combined experience, we’ve been the reliable allies our clients need, tackling financial hardships, physical pain, and major life changes. Our track record of successful verdicts and settlements speaks to our team’s passion and dedication to helping clients get the support and justice they need.
$11.6 Million Verdict in Catastrophic Injury Case
Summary: Served as trial counsel and obtained an $11.6 million jury verdict in a Houston, Texas case involving a worker who suffered a catastrophic injury that resulted in the loss of most of the sight in one of his eyes. The jury deliberated for only a day and a half before finding the defendant liable for designing a faulty piece of equipment that led to the injuries. The pretrial settlement offer was less than $300,000.
$2.4 Million Verdict for Injured Refinery Worker
Summary: Paul helped an injured refinery worker obtain a $2.4 Million verdict in the 80th Judicial District of Harris County. The jury award was unanimous. Paul took three of the seven witnesses at trial and got a defense expert struck on voir dire during trial. The Plaintiff suffered second and third-degree burns to 20% of his body. His claims were against an engineering company that designed the equipment that caused his injuries. Defendant’s final offer prior to trial was $135,000.
